Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pharmacological PrP-Silencing Accelerates CNS Autoimmune Disease Via TCR Signaling
MS and Related Diseases
(-)
004
Authors/Disclosures
Sima S. Zein, PhD (UT Southwestern Medical Center) No disclosure on file
Sarah E. Buckingham, MD (Stamford Health Medical Group) No disclosure on file
Wei Hu, MD, PhD (University of Florida) No disclosure on file
Stefan Nessler, MD (University Medical Center Goettingen) No disclosure on file
Bernhard Hemmer, MD (Technische Universität München) No disclosure on file
Bridgette J. Billioux, MD Dr. Billioux has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Anne Gocke No disclosure on file
Amy E. Lovett Racke, PhD (Ohio State University) No disclosure on file
No disclosure on file
No disclosure on file
Jeffrey L. Elliott, MD (UT Southwestern Medical Center) No disclosure on file
No disclosure on file
Petra Cravens, PhD (UTSWMC) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Michael K. Racke, MD (Quest Diagnostics) Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Olaf Stuve, MD, PhD, FAAN (UT Southwestern Medical Center) Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.